These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18191541)

  • 21. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
    Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
    J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
    Aleksandrova EN; Novikov AA; Popkova TV; Reshetniak TM; Novikova DS; Kliukvina NG; Il'ina AE; Mach ES; Volkov AV; Nasonov EL
    Ter Arkh; 2006; 78(6):35-9. PubMed ID: 16881361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody clustering helps refine lupus prognosis.
    Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
    Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, systemic lupus erythematosus and monoclonal gammopathies.
    Krause I; Cohen J; Blank M; Bakimer R; Cartman A; Hohmann A; Valesini G; Asherson RA; Khamashta MA; Hughes GR
    Lupus; 1992 Feb; 1(2):91-6. PubMed ID: 1301969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
    Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
    J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
    Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
    Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
    Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
    Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays.
    Villalta D; Tozzoli R; Bizzaro N; Tonutti E; Ghirardello A; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1050():176-84. PubMed ID: 16014532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic anti-nucleosome antibodies.
    Muller S; Dieker J; Tincani A; Meroni PL
    Lupus; 2008 May; 17(5):431-6. PubMed ID: 18490422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS).
    Ehrenstein MR; Swana M; Keeling D; Asherson R; Hughes GR; Isenberg DA
    Br J Rheumatol; 1993 May; 32(5):362-5. PubMed ID: 8495254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value.
    Gómez-Puerta JA; Burlingame RW; Cervera R
    Autoimmun Rev; 2008 Sep; 7(8):606-11. PubMed ID: 18606252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
    Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against the N-terminal domain of annexin A2 in antiphospholipid syndrome.
    Salle V; Mazière JC; Brulé A; Schmidt J; Smail A; Duhaut P; Mazière C; Makdassi R; Choukroun G; Betsou F; Ducroix JP
    Eur J Intern Med; 2012 Oct; 23(7):665-8. PubMed ID: 22939813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein: discriminator between patients with primary and secondary antiphospholipid syndrome.
    Bećarević M; Majkić-Singh N
    Clin Biochem; 2008 Dec; 41(18):1449-53. PubMed ID: 18801352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.